1,073
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Safety Evaluation of the Aqueous Extract Kothala Himbutu (Salacia reticulata) Stem in the Hepatic Gene Expression Profile of Normal Mice Using DNA Microarrays

, , , &
Pages 3075-3083 | Received 15 Nov 2007, Accepted 19 Aug 2008, Published online: 22 May 2014

  • 1) Warrir, P. K., Nambir, V. P. K., and Ramankutty, C., Salacia reticulata wight. In “Indian Medical Plants,” Orient Longman, Chennai, pp. 47–48 (1993).
  • 2) Jayawardena, M. H., de Alwis, N. M., Hettigoda, V., and Fernando, D. J., A double blind randomized placebo controlled cross over study of a herbal preparation containing Salacia reticulata in the treatment of type 2 diabetes. J. Ethnopharmacol., 97, 215–218 (2005).
  • 3) Karunanayake, E. H., Welihinda, J., Sirimanne, S. R., and Sinnadorai, G., Oral hypoglycaemic activity of some medicinal plants of Sri Lanka. J. Ethnopharmacol., 11, 223–231 (1984).
  • 4) Kajimoto, O., Kawamori, S., Shimoda, H., Kawahara, Y., Hirata, H., and Takahashi, T., Effects of a diet containing Salacia reticulata on mild type 2 diabetes in humans. J. Jpn. Soc. Nutr. Food Sci., 53, 199–205 (2000).
  • 5) Im, R., Mano, H., Matsuura, T., Nakatani, S., Shimizu, J., and Wada, M., Mechanisms of blood glucose-lowing effect of aqueous extract from stems of Kothala himburu (Salacia reticulata) in the mouse. J. Ethnopharmacol., in press.
  • 6) Swinbanks, D., and O’Brien, J., Japan explores the boundary between food and medicine. Nature, 364, 180 (1993).
  • 7) Arai, S., Morinaga, Y., Yoshikawa, T., Ichiishi, E., Kiso, Y., Yamazaki, M., Morotomi, M., Shimizu, M., Kuwata, T., and Kaminogawa, S., Recent trends in functional food science and the industry in Japan. Biosci. Biotechnol. Biochem., 66, 2017–2029 (2002).
  • 8) Shimoda, H., Furuhashi, T., Naitou, K., Nagase, T., and Okada, M., Thirteen-week repeat dose oral toxicity study of Salacia reticulata extract in rats. Jpn. J. Med. Pharm. Sci., 46, 527–541 (2001).
  • 9) Arai, S., Studies on functional foods in Japan: state of the art. Biosci. Biotechnol. Biochem., 60, 9–15 (1996).
  • 10) Muller, M., and Kersten, S., Nutrigenomics: goals and strategies. Nat. Rev. Genet., 4, 315–322 (2003).
  • 11) Narasaka, S., Endo, Y., Fu, Z., Moriyama, M., Arai, S., Abe, K., and Kato, H., Safety evaluation of hypoallergenic wheat flour by using a DNA microarray. Biosci. Biotechnol. Biochem., 70, 1464–1470 (2006).
  • 12) Kamakura, M., Maebuchi, M., Ozasa, S., Komori, M., Ogawa, T., Sakaki, T., and Moriyama, T., Influence of royal jelly on mouse hepatic gene expression and safety assessment with a DNA microarray. J. Nutr. Sci. Vitaminol., 51, 148–155 (2005).
  • 13) Hosake, D. A., Dennis, G., Jr., Sherman, B. T., Lane, H. C., and Lempicki, R. A., Identifying biological themes within lists of genes with EASE. Genome Biol., 4, R70 (2003).
  • 14) Dennis, G., Jr., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., and Lempicki, R. A., DAVID: database for annotation, visualization, and integrated discovery. Genome Biol., 4, P3 (2003).
  • 15) Moller, D. E., New drug targets for type 2 diabetes and the metabolic syndrome. Nature, 414, 821–827 (2001).
  • 16) Guengerich, F. P., and Shimada, T., Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol., 4, 391–407 (1991).
  • 17) Lynch, T., and Price, A., The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am. Fam. Physician., 76, 391–396 (2007).
  • 18) Faber, M. S., Jetter, A., and Fuhr, U., Assessment of CYP1A2 activity in clinical practice: why, how, and when? Basic Clin. Pharmacol. Toxicol., 97, 125–134 (2005).
  • 19) Miners, J. O., and Birkett, D. J., Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br. J. Clin. Pharmacol., 45, 525–538 (1998).
  • 20) Goldstein, J. A., Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br. J. Clin. Pharmacol., 52, 349–355 (2001).
  • 21) Mei, N., Guo, L., Zhang, L., Shi, L., Sun, Y. A., Fung, C., Moland, C. L., Dail, S. L., Fuscoe, J. C., and Chen, T., Analysis of gene expression changes in relation to toxicity and tumorigrnrsis in the livers of Big Blue transgenic rats fed comfrey (Symphytum officinale). BMC Bioinformatics, 7, S16 (2006).
  • 22) Gue, L., Mei, N., Dail, S., Fuscoe, J., and Chen, T., Comparison of gene expression profiles altered by comfrey and riddelliine in rat liver. BMC Bioinformatics, 8, S22 (2007).
  • 23) Stadlbauer, V., Fickert, P., Lackner, C., Schmerlaib, J., Krisper, P., Trauner, M., and Stauber, R. E., Hepatotoxicity of NONI juice: report of two cases. World J. Gastroenterol., 14, 4758–4760 (2005).
  • 24) Vitetta, L., Thomsen, M., and Sali, A., Black cohosh and other herbal remedies associated with acute hepatitis. Med. J. Australia, 180, 598–600 (2004).
  • 25) Yoshikawa, M., Ninomiya, K., Shimoda, H., Nishida, N., and Matsuda, H., Hepatoprotective and antioxidative properties of Salacia reticulata: preventive effects of phenolic constituents on CCl4-induced liver injury in mice. Biol. Pharm. Bull., 25, 72–76 (2002).
  • 26) Yoshikawa, M., Shimoda, H., Nishida, N., Takada, M., and Matsuda, H., Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats. J. Nutr., 132, 1819–1824 (2002).
  • 27) Kishino, E., Ito, T., Fujita, K., and Kiuchi, Y., A mixture of the Salacia reticulata (Kotala himbutu) aqueous extract and cyclodextrin reduces the accumulation of visceral fat mass in mice and rats with high-fat diet-induced obesity. J. Nutr., 19, 433–439 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.